Shigella "Osp"pression of innate immunity.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35750030.
- Also identified by DOI 10.1016/j.cell.2022.05.027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interferons are potent antimicrobial effectors and thus an attractive target for pathogen interference. In this issue of Cell, Alphonse et al. reveal that the Shigella effectors OspC1 and OspC3 employ a surprising mechanism to block interferon signaling and attenuate antibacterial responses, thus securing their replicative niche.
Medical subject headings
- Dysentery, Bacillary
- Shigella